RIIPL conference: After Actavis: Litigating Reverse Payments Register Now Since the landmark United States Supreme Court decision in FTC v. Actavis, courts use the rule of reason to scrutinize payments from brand drug companies to generic drug companies in settling patent infringement cases. But how should they do so? What must plaintiffs show to invoke … Continue reading RIIPL conference: Feb. 27 at USF Law School…
Category: News
Professor Ellen Goodman to Speak on European Right to be Forgotten
OF SEARCH ENGINES, UNFOLDING JURISDICTION AND THE CLAIMS OF PRIVACY: THE DRAMA OF INTERNET POLICY AND THE RIGHT TO BE FORGOTTEN JANUARY 29, 2015 06:00PM – 08:00PM CARDOZO SCHOOL OF LAW, ROOM 206 55 FIFTH AVENUE NEW YORK CITY, Panel Discussion Featuring Professor Ellen Goodman (Rutgers University) and Marcel Leonardi (Senior Public Policy Counsel, Google) The European Court … Continue reading Professor Ellen Goodman to Speak on European Right to be Forgotten…
WSJ’s Q&A with Michael Carrier
The Wall Street Journal published Why the FTC Lawsuit over Pay-To-Delay Deals Matters – Carrier Explains, a Q&A with Michael Carrier. Carrier discussed the Federal Trade Commission’s lawsuit, which alleged antitrust violations by Abbott for filing frivolous patent litigation and by Abbott and Teva for entering into a settlement to delay generic entry. Carrier explained … Continue reading WSJ’s Q&A with Michael Carrier…
Michael Carrier on Bloomberg Radio on Lawsuit Against Alzheimer’s Manufacturer
The New York Attorney General filed a lawsuit against Actavis and Forest for pulling the old version of its Alzheimer’s treatment Naminda. In this interview with Bloomberg Radio, Professor Carrier explores the consequences of this development.
Michael Carrier testifies to U.S. Senate committee
http://www.c-spanvideo.org/program/PatentS Michael Carrier testified before the U.S. Senate Judiciary Committee’s Subcommittee on Antitrust, Competition Policy and Consumer Rights at a hearing entitled “Pay-for-Delay Deals: Limiting Competition and Costing Consumers” that was televised on C-SPAN. He provided support for congressional legislation to address the problem of settlements by which brand-name drug companies pay generics to delay … Continue reading Michael Carrier testifies to U.S. Senate committee…